Disc Medicine, Inc.
IRON
$59.14
-$0.85-1.41%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 97.83% | 78.65% | 68.57% | 51.88% | 51.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 81.29% | 63.03% | 52.06% | 41.80% | 42.35% |
| Operating Income | -81.29% | -63.03% | -52.06% | -41.80% | -42.35% |
| Income Before Tax | -94.33% | -74.94% | -59.46% | -44.10% | -42.80% |
| Income Tax Expenses | 1.69% | 112.80% | 294.02% | 479.01% | 258.59% |
| Earnings from Continuing Operations | -94.03% | -75.02% | -59.76% | -44.54% | -43.08% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -94.03% | -75.02% | -59.76% | -44.54% | -43.08% |
| EBIT | -81.29% | -63.03% | -52.06% | -41.80% | -42.35% |
| EBITDA | -81.29% | -63.10% | -52.20% | -41.80% | -42.34% |
| EPS Basic | -50.10% | -34.97% | -22.19% | -16.22% | -14.18% |
| Normalized Basic EPS | -49.72% | -32.82% | -19.92% | -16.16% | -14.26% |
| EPS Diluted | -50.10% | -34.97% | -22.19% | -16.22% | -14.18% |
| Normalized Diluted EPS | -49.72% | -32.82% | -19.92% | -16.16% | -14.26% |
| Average Basic Shares Outstanding | 27.88% | 27.36% | 29.28% | 25.08% | 23.75% |
| Average Diluted Shares Outstanding | 27.88% | 27.36% | 29.28% | 25.08% | 23.75% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |